Page last updated: 2024-08-24

diphenylcyclopropenone and Alopecia Areata

diphenylcyclopropenone has been researched along with Alopecia Areata in 145 studies

Research

Studies (145)

Timeframe	Studies, this research(%)	All Research%
pre-1990	19 (13.10)	18.7374
1990's	40 (27.59)	18.2507
2000's	24 (16.55)	29.6817
2010's	44 (30.34)	24.3611
2020's	18 (12.41)	2.80

Authors

Authors	Studies
Abedini, R; Ehsani, A; Etesami, I; Ghandi, N; Mirabedian, S; Nasimi, M; Seifi, G	1
Abedini, R; Al Bazzal, A; Ayanian, Z; Etesami, I; Ghandi, N; Hatami, P	1
Díaz-Guimaraens, B; Dominguez-Santas, M; Hermosa-Gelbard, Á; Moreno-Arrones, ÓM; Saceda-Corralo, D; Suarez-Valle, A; Vañó-Galván, S	1
Apalla, Z; Chatzopoulos, S; Fotiadou, C; Ioannides, D; Kemanetzi, C; Koletsa, T; Kyrmanidou, E; Lazaridou, E; Sotiriou, E	1
Daroach, M; De, D; Handa, S; Mahajan, R	1
Kim, JI; Lee, GJ; Nam, KH; Park, J; Song, KH	1
Friedman, AJ	1
Heo, YW; Lee, SH; Lee, WS	1
Bennouna-Dalero, T; Correa-Pérez, A; Fernández-García, S; Gaetano Gil, A; Giraldo, L; Mateos-Haro, M; Novoa-Candia, M; Ortega-Quijano, D; Saceda-Corralo, D; Sánchez Vanegas, G; Tomlinson, J; Urueña Rodriguez, MG; Vaño-Galván, S; Zamora, J	1
Aydın, Ö; Kutlubay, Z; Serdaroğlu, S; Sevim, A; Vehid, S	1
Kim, BJ; Lee, CH; Lee, S; Lee, WS	1
Chandrashekar, L; Manimaran, RP; Rajappa, M; Ramassamy, S	1
Abedini, R; Ghandi, N; Mehdizade, MS; Nasimi, M; Seirafi, H; Tootoonchi, N	1
Chandran, NS; Leong, WMS; Mok, ZR	1
Gong, Y; He, X; Li, L; Lu, W; Luo, L; Mao, Y; Sha, X	1
Abedini, R; Aryanian, Z; Daneshmand, R; Ghandi, N; Hatami, P; Nasimi, M; Vance, TM	1
Jang, YH; Jung, HJ; Kim, DW; Lee, SJ; Lee, WJ; Lee, WK; Moon, SY	1
Lee, S; Lee, WS	1
Bergfeld, W; Murad, A	1
Choe, SJ; Keum, DI; Kim, BJ; Lee, CH; Lee, S; Lee, WS; Pi, LQ	1
Choe, SJ; Choi, J; Lee, H; Lee, S; Lee, WS	1
Harries, M; Karanovic, S; Kaur, MR	1
Borowska, K; Wasylyszyn, T	2
Caulloo, S; Gong, Y; Li, S; McElwee, KJ; Qi, S; Yang, J; Ye, Y; Zhang, X; Zhao, Y	1
Kim, BJ; Lee, S; Lee, WS; Lee, YB	1
Abedini, R; Ghandi, N; Mirshamsi, A; Nasimi, M; Seirafi, H; Shakoei, S	1
Abdelshafy, AS; Esawy, AM; Ibrahim, SA	1
Gómez-Flores, M; Herz-Ruelas, ME; Lozano-Peña, AK; Ocampo-Candiani, J; Vázquez-Martínez, O; Welsh-Lozano, O	1
Adisesh, A; Basu, S	1
Abdel-Raheem, HM; Azzam, OA; Bassiouny, DA; El-Zawahry, BM; Khorshied, MM; Zaki, NS	1
Abbas, O; Abd-el-Baki, J; El Khoury, J; Kibbi, AG; Kurban, M; Succariah, F	1
Shapiro, J	2
Donati, A; Hordinsky, M	1
Amoretti, A; Atanaskova Mesinkovska, N; Bergfeld, WF; Chiang, K; Kyei, A; Piliang, MP	1
Li, B; Liu, J; Pan, R; Xuan, X	1
Baba, M; Durdu, M; Özcan, D; Seçkin, D	1
Brugia, M; Campanati, A; Ganzetti, G; Giuliodori, K; Offidani, A; Scocco, V; Simonetti, O; Tocchini, M	1
Perera, E; Sinclair, R; Yip, L	1
Donovan, JC; Spano, F	1
Kuin, RA; Limpens, J; Spuls, PI; van Zuuren, EJ	1
Bulock, KG; Cardia, JP; Levis, WR; Pavco, PA	1
Bergfeld, WF; Chiang, KS; Mesinkovska, NA; Piliang, MP	1
Holmes, S; Lamb, RC; Young, D	1
Engin, B; Kutlubay, Z; Serdaroglu, S; Songur, A; Tuzun, Y	1
Borowska, K; Wasyłyszyn, T	1
Daneshpazhooh, M; Mahmoudi, HR; Rahimzadeh, G; Tavakolpour, S	1
Choe, SJ; Lee, WS	1
Choe, SJ; Choi, J; Kim, BJ; Lee, WS	1
Inui, S; Itami, S; Nakajima, T; Toda, N	2
Burkhart, CN; Morrell, DS; Mukherjee, N	1
Bassiouny, DA; El-Zawahry, BM; Khella, A; Zaki, NS	1
Ajami, M; Akhiani, M; Babakoohi, S; Firooz, A; Habibey, R; Khaki, L; Pazoki-Toroudi, H; Seirafi, H	1
Alkhalifah, A; Alsantali, A; McElwee, KJ; Shapiro, J; Wang, E	1
Gregoriou, S; Kalogeromitros, D; Kontochristopoulos, G; Papafragkaki, D; Rallis, E; Rigopoulos, D	1
Hunter, N; Marei, N; Shaker, O	1
Campanati, A; Ganzetti, G; Giuliodori, K; Offidani, A; Simonetti, O	1
Böhm, M; Luger, TA; Ohlmeier, MC; Traupe, H	1
Lee, MH; Oh, YJ; Shin, MK	1
Häffner, A; Johansen, P; Kündig, TM; Mohanan, D; Senti, G; von Moos, S; Waeckerle-Men, Y	1
Donovan, J; Salsberg, JM	1
Chang, M; Chau, CT; Chiu, LS; Lam, YK; Lee, HC; Lee, KC; Lee, VW; Luk, NM	1
Al-Suwayeh, SA; Fang, JY; Leu, YL; Lin, YK; Shen, FM	1
Fransson, J; Heffler, LC; Jacobsson Ekman, G; Kastman, AL; Scheynius, A	1
Francomano, M; Seidenari, S	1
Bissonnette, R; Lui, H; McLean, DI; Shapiro, J; Sundberg, JP; Tang, L	1
Usatine, RP	1
Alkaabi, J; Galadari, H; Galadari, I; Rubaie, S	1
Bernardini, ML; Biagini, G; Lucarini, G; Offidani, A; Simoncini, C; Simonetti, O	1
Hoffmann, R; McElwee, KJ; Vitacolonna, M; Zöller, M	1
Henderson, RL; McMichael, AJ	1
Bouzari, N; Davoudi, M; Dowlati, Y; Firooz, A; Mojtahed, F; Nassiri-Kashani, M; Pazoki-Toroudi, H	1
Aghaei, S	1
Arakawa, S; Fujiwara, S; Hatano, Y; Katagiri, K	1
Chrysomallis, F; Kastanis, A; Lazaridou, E; Patsatsi, A; Sotiriadis, D; Vakirlis, E	1
Kozłowski, W; Wasyłyszyn, T; Zabielski, SL	1
Avgerinou, G; Gregoriou, S; Kalogeromitros, D; Katsambas, A; Rigopoulos, D; Stratigos, A	1
Happle, R; Hausen, BM; Wiesner-Menzel, L	1
Happle, R; Hoffmann, R	1
Braathen, LR; Finkel, B; Friedli, A; Hunziker, T	1
Ho, V; Shapiro, J; Tan, J; Tron, V	1
Happle, R; Henninger, HP; Hoffmann, R; Huth, A; Schäufele, M; van der Steen, P; Wenzel, E	1
Berth-Jones, J; Hutchinson, PE; Mc Burney, A	1
Happle, R; van der Steen, PH	1
Henderson, CA; Ilchyshyn, A	1
Ro, BI	1
Böni, R; Trüeb, RM; Wüthrich, B	1
Goldberg, B; Stricker, RB	1
Happle, R; Hoffmann, R; Huth, A; König, A; Schäufele, M; van der Steen, P; Wenzel, E	1
Eun, HC; Seo, KI	1
Aldrige, RD; Gordon, PM; Hunter, JA; McVittie, E	1
Lewis, FM; Messenger, AG; Shah, M	1
Hamm, H; John, SM; Kretzschmar, L; Weise, K	1
Hamstra, JJ; Mulder, PG; Oranje, AP; Peereboom-Wynia, JD; Plinck, EP; Schuttelaar, ML; Vuzevski, VD	1
Lebwohl, M	1
Happle, R; Hoffmann, R; König, A	1
Pericin, M; Trüeb, RM	1
Rokhsar, CK; Shupack, JL; Vafai, JJ; Washenik, K	1
Alam, M; Gross, EA; Savin, RC	1
Freyschmidt-Paul, P; Hamm, H; Happle, R; Hoffmann, R	1
Muralidhar, S; Sharma, VK	1
Buckley, DA; du Vivier, AW	2
Orecchia, G; Stock, J	1
Havu, VK; Lammintausta, K	1
Bissonnette, R; Carroll, JM; Lui, H; McElwee, KJ; McLean, DI; Oliver, RF; Shapiro, J; Sundberg, JP; Tang, L	1
Fernández-Redondo, V; Flórez, A; Gómez-Centeno, P; Toribio, J	1
Bolduc, C; Shapiro, J	1
Caracciolo, E; Chimenti, S; Cotellessa, C; Mordenti, C; Peris, K	1
Lui, H; MacDonald, N; Shapiro, J; Wiseman, MC	1
Ando, Y; Asada, H; Fujii, H; Itami, S; Yamaguchi, Y; Yoshikawa, K; Yoshino, T	1
MacDonald, N; Shapiro, J; Wiseman, MC	1
Happle, R	1
Friedli, A; Harms, M	1
Boezeman, JB; Happle, R; van der Steen, PH	1
Boehm, A; Hoting, E	1
Cunliffe, WJ; Hull, SM	2
Cunliffe, WJ; Hull, SM; Pepall, L	1
Boezeman, JB; Happle, R; Perret, CM; van Baar, HM; van der Steen, PH	1
Happle, R; Perret, CM; van Baar, HM; van der Steen, PH	1
Bröcker, EB; Hamm, H; John, SM; Steinhausen, D	1
Happle, R; Perret, CM; Steijlen, PM; Zaun, H	1
Cainelli, T; Naldi, L; Parazzini, F	1
Cunliffe, WJ; Hull, SM; Norris, JF	1
Hardung, H; Kietzmann, H	1
Perret, CM	1
Kreysel, HW; Lutz, G	1
Orecchia, G; Perfetti, L	1
Monk, B	1
Happle, R; Perret, CM; Steijlen, PM	1
Bardazzi, F; Guerra, L; Tosti, A	1
Happle, R; Klein, HM; Macher, E	1
Anastasiadis, G; Georgiotouo, K; Hatzis, J; Kostakis, P; Straigos, J; Tosca, A; Varelzidis, A	1
Gasponi, A; Manuzzi, P; Tosti, A	1
Hull, SM; Norris, JF	1
Christophers, E; Hardung, H; Kietzmann, H	1
Gourgiotou, K; Hatzis, J; Stratigos, J; Tosca, A; Varelzidis, A	1
Brasile, GP; Capobianco, C; Guerra, L; Tosti, A	1
Milbradt, R; Mitrou, G; Ochsendorf, FR	1
Orecchia, G; Rabbiosi, G	2
De Padova, MP; Minghetti, G; Tosti, A; Veronesi, S	1

Reviews

20 review(s) available for diphenylcyclopropenone and Alopecia Areata

Article	Year
Treatments for alopecia areata: a network meta-analysis. The Cochrane database of systematic reviews, 2023, 10-23, Volume: 10 Topics: Adolescent; Adult; Aged; Alopecia Areata; Betamethasone; Biological Products; Child; Child, Preschool; Cyclosporins; Humans; Immunosuppressive Agents; Middle Aged; Minoxidil; Network Meta-Analysis; Prednisolone; Young Adult	2023
Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata. Journal of the American Academy of Dermatology, 2017, Volume: 77, Issue:1 Topics: Administration, Cutaneous; Alopecia Areata; Cyclopropanes; Dermatologic Agents; Humans; Research Design	2017
Treatment for facial alopecia areata: A systematic review with evidence-based analysis. Journal of the American Academy of Dermatology, 2018, Volume: 78, Issue:3 Topics: 11-beta-Hydroxysteroid Dehydrogenases; Alopecia Areata; Anthralin; Bimatoprost; Cyclopropanes; Dermatologic Agents; Drug Therapy, Combination; Eyebrows; Eyelashes; Facial Dermatoses; Humans; Latanoprost; Minoxidil; Photosensitizing Agents; Prostaglandins F, Synthetic	2018
Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis. JAMA dermatology, 2018, 10-01, Volume: 154, Issue:10 Topics: Adjuvants, Immunologic; Alopecia; Alopecia Areata; Cyclobutanes; Cyclopropanes; Hair; Humans; Immunotherapy; Recurrence	2018
Current treatment of alopecia areata. The journal of investigative dermatology. Symposium proceedings, 2013, Volume: 16, Issue:1 Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Alopecia Areata; Anthralin; Cyclobutanes; Cyclopropanes; Cyclosporine; Dermatologic Agents; Humans; Immunosuppressive Agents; Injections, Intralesional; Methotrexate; Minoxidil; PUVA Therapy; Self-Help Groups	2013
Alopecia areata: an evidence-based treatment update. American journal of clinical dermatology, 2014, Volume: 15, Issue:3 Topics: Alopecia Areata; Cyclopropanes; Dinitrochlorobenzene; Evidence-Based Medicine; Glucocorticoids; Humans; Randomized Controlled Trials as Topic	2014
Alopecia areata. Current problems in dermatology, 2015, Volume: 47 Topics: Administration, Topical; Adrenal Cortex Hormones; Alopecia Areata; Anthralin; Autoimmunity; Cyclopropanes; Cyclosporine; Dermatitis, Allergic Contact; Dermatologic Agents; Humans; Immunosuppressive Agents; Immunotherapy; Injections, Intralesional; Minoxidil; Vasodilator Agents	2015
Alopecia areata: Part 2: treatment. Canadian family physician Medecin de famille canadien, 2015, Volume: 61, Issue:9 Topics: Adult; Alopecia Areata; Anthralin; Child; Cyclopropanes; Dermatologic Agents; Humans; Immunosuppressive Agents; Primary Health Care; Referral and Consultation; Steroids	2015
Diphenylcyclopropenone in patients with alopecia areata. A critically appraised topic. The British journal of dermatology, 2015, Volume: 173, Issue:4 Topics: Adolescent; Adult; Aged; Alopecia Areata; Child; Child, Preschool; Cyclopropanes; Dermatologic Agents; Female; Humans; Male; Middle Aged; Treatment Outcome; Young Adult	2015
Treatment of alopecia areata in children. Pediatric annals, 2009, Volume: 38, Issue:7 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Alopecia Areata; Anthralin; Child; Child, Preschool; Cyclobutanes; Cyclopropanes; Dermatologic Agents; Dinitrochlorobenzene; Glucocorticoids; Humans; Immunosuppressive Agents; Immunotherapy; Minoxidil; Phototherapy; Practice Guidelines as Topic; Treatment Outcome; Vasodilator Agents	2009
Alopecia areata update: part II. Treatment. Journal of the American Academy of Dermatology, 2010, Volume: 62, Issue:2 Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia Areata; Animals; Child; Cyclopropanes; Cyclosporine; Hair; Haptens; Humans; Immunotherapy; Injections, Intralesional; Laser Therapy; Methotrexate; Minoxidil; Photochemotherapy; Randomized Controlled Trials as Topic; Rats; Recurrence; Research Design; Social Support; Sulfasalazine; Treatment Outcome; Triamcinolone Acetonide	2010
Cytokines and other mediators in alopecia areata. Mediators of inflammation, 2010, Volume: 2010 Topics: Alopecia Areata; Cyclopropanes; Cytokines; fas Receptor; Hair Follicle; Humans; Inflammation Mediators; Interferon-gamma; Leukocytes, Mononuclear; Macrophage Migration-Inhibitory Factors; Major Histocompatibility Complex; Stress, Physiological; Tumor Necrosis Factor-alpha	2010
Topical sensitizers in alopecia areata. Dermatology nursing, 2004, Volume: 16, Issue:4 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Alopecia Areata; Cyclobutanes; Cyclopropanes; Dinitrochlorobenzene; Humans; Inflammation; Irritants; Patient Selection; Prognosis; Severity of Illness Index; Treatment Outcome	2004
Topical immunotherapy in the treatment of chronic severe alopecia areata. Dermatologic clinics, 1993, Volume: 11, Issue:3 Topics: Administration, Topical; Allergens; Alopecia Areata; Chronic Disease; Cyclobutanes; Cyclopropanes; Dinitrochlorobenzene; Hair; Humans; Immunotherapy	1993
Efficacy of topical sensitizers in the treatment of alopecia areata. Journal of the American Academy of Dermatology, 1998, Volume: 39, Issue:5 Pt 1 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Alopecia Areata; Cyclobutanes; Cyclopropanes; Hair; Humans; Prognosis; Safety	1998
Topical immunotherapy in dermatology. International journal of clinical practice, 1999, Volume: 53, Issue:2 Topics: Administration, Topical; Allergens; Alopecia Areata; Cyclobutanes; Cyclopropanes; Decision Making; Dinitrochlorobenzene; Humans; Immunotherapy; Warts	1999
The therapeutic use of topical contact sensitizers in benign dermatoses. The British journal of dermatology, 2001, Volume: 145, Issue:3 Topics: Allergens; Alopecia Areata; Cyclopropanes; Dinitrochlorobenzene; Female; Humans; Immunotherapy; Irritants; Male; Warts	2001
Alopecia areata: topical immunotherapy--application and practical problems. Journal of cutaneous medicine and surgery, 1999, Volume: 3 Suppl 3 Topics: Administration, Topical; Alopecia Areata; Cyclopropanes; Humans; Immunotherapy; Patient Education as Topic	1999
Role of topical immunotherapy in the treatment of alopecia areata. Quality analysis of articles published between January 1977 and January 1988 about three treatments. Reading Group. Journal of the American Academy of Dermatology, 1990, Volume: 22, Issue:4 Topics: Administration, Cutaneous; Alopecia Areata; Cyclobutanes; Cyclopropanes; Dinitrochlorobenzene; Humans; Immunotherapy; Meta-Analysis as Topic	1990
[Alopecia areata; pathogenesis and topical immunotherapy]. Nederlands tijdschrift voor geneeskunde, 1989, Jun-24, Volume: 133, Issue:25 Topics: Allergens; Alopecia Areata; Cyclobutanes; Cyclopropanes; Female; Humans; Male	1989

Trials

23 trial(s) available for diphenylcyclopropenone and Alopecia Areata

Article	Year
A prospective comparative study of two regimens of diphenylcyclopropenone (DPCP) in the treatment of alopecia areata. International immunopharmacology, 2021, Volume: 101, Issue:Pt B Topics: Adolescent; Adult; Alopecia Areata; Cyclopropanes; Dermatitis, Contact; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Young Adult	2021
Randomized controlled trial to compare the effectiveness and safety of low dose dexamethasone oral mini-pulse versus diphenylcyclopropenone contact sensitisation in severe pediatric alopecia areata. Dermatologic therapy, 2022, Volume: 35, Issue:11 Topics: Alopecia Areata; Child; Cyclopropanes; Dexamethasone; Humans; Treatment Outcome	2022
A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata. International immunopharmacology, 2021, Volume: 99 Topics: Adolescent; Adult; Age of Onset; Alopecia Areata; Anthralin; Chronic Disease; Cyclopropanes; Drug Therapy, Combination; Female; Hair; Humans; Immunotherapy; Male; Middle Aged; Nail Diseases; Prospective Studies; Treatment Outcome; Young Adult	2021
Effects of diphencyprone on expression of Bcl-2 protein in patients with alopecia areata. Immunopharmacology and immunotoxicology, 2010, Volume: 32, Issue:3 Topics: Alopecia Areata; Apoptosis; Cyclopropanes; Female; Hair Follicle; Humans; Male; Proto-Oncogene Proteins c-bcl-2; Treatment Outcome	2010
Diphencyprone and topical tacrolimus as two topical immunotherapeutic modalities. Are they effective in the treatment of alopecia areata among Egyptian patients? A study using CD4, CD8 and MHC II as markers. The Journal of dermatological treatment, 2011, Volume: 22, Issue:1 Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Antibodies, Monoclonal; Biomarkers; CD4 Antigens; CD8 Antigens; Child; Cyclopropanes; Egypt; Female; Histocompatibility Antigens Class II; Humans; Immunohistochemistry; Immunosuppressive Agents; Male; Scalp Dermatoses; T-Lymphocyte Subsets; Tacrolimus; Treatment Outcome; Young Adult	2011
Topical immunotherapy with diphenylcyclopropenone of patients with alopecia areata--a large retrospective study on 142 patients with a self-controlled design. Journal of the European Academy of Dermatology and Venereology : JEADV, 2012, Volume: 26, Issue:4 Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Alopecia Areata; Child; Cyclopropanes; Female; Humans; Immunotherapy; Male; Middle Aged; Retrospective Studies; Young Adult	2012
Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA). European annals of allergy and clinical immunology, 2003, Volume: 35, Issue:10 Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Child; Chronic Disease; Cyclopropanes; Female; Humans; Immunotherapy; Male; Middle Aged; Treatment Outcome	2003
Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population. BMC dermatology, 2005, May-26, Volume: 5 Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Child; Cyclopropanes; Dermatologic Agents; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hair; Humans; Immunotherapy; Male; Prospective Studies; Treatment Outcome	2005
Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata. Clinical and experimental dermatology, 2007, Volume: 32, Issue:1 Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Child; Cyclopropanes; Dermatologic Agents; Female; Humans; Immunotherapy; Male; Middle Aged; Prospective Studies	2007
Alopecia areata: topical immunotherapy treatment with diphencyprone. Journal of the European Academy of Dermatology and Venereology : JEADV, 2008, Volume: 22, Issue:3 Topics: Administration, Topical; Adult; Alopecia Areata; Cyclopropanes; Dose-Response Relationship, Drug; Female; Hair; Humans; Immunotherapy; Male; Middle Aged; Treatment Outcome	2008
Diphencyprone in the treatment of alopecia areata. Acta dermato-venereologica, 1983, Volume: 63, Issue:1 Topics: Adolescent; Adult; Alopecia; Alopecia Areata; Chemical Phenomena; Chemistry; Cyclopropanes; Dermatitis, Contact; Female; Hair; Humans; Male; Middle Aged; Time Factors	1983
Treatment of severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation. The Journal of investigative dermatology, 1995, Volume: 104, Issue:5 Suppl Topics: Administration, Cutaneous; Alopecia Areata; Cyclopropanes; Double-Blind Method; Drug Combinations; Gene Expression; Hair; Humans; Intercellular Adhesion Molecule-1; Langerhans Cells; Minoxidil; Placebos; T-Lymphocytes	1995
Cytokine mRNA levels in Alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. The Journal of investigative dermatology, 1994, Volume: 103, Issue:4 Topics: Adult; Aged; Allergens; Alopecia Areata; Biopsy; Chromatography, High Pressure Liquid; Cyclopropanes; Cytokines; Dermatitis, Contact; Humans; Middle Aged; Polymerase Chain Reaction; RNA, Messenger; Scalp	1994
Alopecia areata in Korea (1982-1994). The Journal of dermatology, 1995, Volume: 22, Issue:11 Topics: Adolescent; Adult; Alopecia Areata; Child; Cyclopropanes; Dinitrochlorobenzene; Female; Glucocorticoids; Humans; Immunotherapy; Injections, Intralesional; Korea; Male; Middle Aged; Triamcinolone Acetonide	1995
Topical diphencyprone for alopecia areata: evaluation of 48 cases after 30 months' follow-up. The British journal of dermatology, 1996, Volume: 134, Issue:5 Topics: Administration, Cutaneous; Adult; Age of Onset; Alopecia Areata; Cyclopropanes; Female; Follow-Up Studies; Humans; Hypersensitivity, Immediate; Male; Nail Diseases; Prognosis; Treatment Outcome	1996
Topical immunotherapy in alopecia areata: anamnestic and clinical criteria of prognostic significance. Dermatology (Basel, Switzerland), 1996, Volume: 192, Issue:2 Topics: Administration, Topical; Adolescent; Adult; Age of Onset; Alopecia Areata; Cyclopropanes; Dermatitis, Atopic; Female; Humans; Immunotherapy; Male; Middle Aged; Nails; Patient Selection; Prognosis	1996
Alopecia areata in children: treatment with diphencyprone. The British journal of dermatology, 1996, Volume: 135, Issue:4 Topics: Adolescent; Alopecia Areata; Child; Child, Preschool; Cyclopropanes; Drug Administration Schedule; Female; Follow-Up Studies; Hair; Humans; Immunotherapy; Male; Treatment Outcome	1996
Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone: evaluation of 68 cases. Dermatology (Basel, Switzerland), 1998, Volume: 196, Issue:4 Topics: Administration, Topical; Adolescent; Adult; Aged; Alopecia Areata; Arthralgia; Blister; Chi-Square Distribution; Cyclopropanes; Eczema; Erythema Multiforme; Female; Fever; Hair; Humans; Hyperpigmentation; Immunoglobulin G; Immunotherapy; Logistic Models; Male; Middle Aged; Retrospective Studies; Serum Sickness; Time Factors; Treatment Outcome	1998
Topical immunotherapy with diphencyprone in Indians with alopecia areata. Clinical and experimental dermatology, 1998, Volume: 23, Issue:6 Topics: Adolescent; Alopecia Areata; Child; Child, Preschool; Cyclopropanes; Humans; Immunotherapy; Male	1998
The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata. Journal of the American Academy of Dermatology, 2001, Volume: 44, Issue:1 Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Chronic Disease; Cyclopropanes; Female; Humans; Male; Middle Aged; Treatment Outcome	2001
Treatment of alopecia areata with diphenylcyclopropenone. Journal of the American Academy of Dermatology, 1991, Volume: 24, Issue:2 Pt 1 Topics: Administration, Topical; Alopecia Areata; Cyclopropanes; Dermatitis, Contact; Eczema; Humans; Immunotherapy; Recurrence	1991
Diphencyprone in the treatment of long-standing alopecia areata. The British journal of dermatology, 1988, Volume: 119, Issue:3 Topics: Adolescent; Adult; Alopecia Areata; Clinical Trials as Topic; Cyclopropanes; Female; Humans; Male; Middle Aged	1988
Therapies versus placebo in the treatment of patchy alopecia areata. Journal of the American Academy of Dermatology, 1986, Volume: 15, Issue:2 Pt 1 Topics: Adolescent; Adult; Age Factors; Aged; Alopecia Areata; Child; Child, Preschool; Clinical Trials as Topic; Cyclobutanes; Cyclopropanes; Female; Humans; Male; Middle Aged; Minoxidil; Placebos	1986

Other Studies

102 other study(ies) available for diphenylcyclopropenone and Alopecia Areata

Article	Year
Is the severity of initial sensitization to diphenylcyclopropenone in alopecia areata patients predictive of the final clinical response? Dermatologic therapy, 2021, Volume: 34, Issue:6 Topics: Alopecia Areata; Cyclopropanes; Humans; Immunotherapy; Retrospective Studies; Treatment Outcome	2021
Imiquimod-enhanced immunotherapy with diphencyprone for patients with alopecia areata. Dermatologic therapy, 2022, Volume: 35, Issue:7 Topics: Adult; Alopecia Areata; Cyclopropanes; Dermatitis, Contact; Female; Hair; Humans; Imiquimod; Immunologic Factors; Immunotherapy; Male; Treatment Outcome	2022
Topical immunotherapy treatment of alopecia areata with diphenylcyclopropenone: Regulatory T cells as biomarkers for treatment response. Dermatologic therapy, 2022, Volume: 35, Issue:7 Topics: Alopecia Areata; Biomarkers; Cyclopropanes; Humans; Immunologic Factors; Immunotherapy; T-Lymphocytes, Regulatory	2022
Home-based diphenylcyclopropenone immunotherapy for alopecia areata: A large retrospective study of 94 cases. The Journal of dermatology, 2023, Volume: 50, Issue:8 Topics: Alopecia Areata; Cyclopropanes; Humans; Immunotherapy; Retrospective Studies	2023
JAAD Game Changer: "Subclinical sensitization with diphenylcyclopropenone is sufficient for the treatment of alopecia areata: Retrospective analysis of 159 cases". Journal of the American Academy of Dermatology, 2023, Volume: 89, Issue:6 Topics: Alopecia Areata; Cyclopropanes; Humans; Retrospective Studies	2023
Long-term prognosis of subclinical sensitization with diphenylcyclopropenone in patients with alopecia areata. Journal of the American Academy of Dermatology, 2023, Volume: 88, Issue:4 Topics: Alopecia Areata; Cyclopropanes; Humans; Prognosis	2023
Assessment of treatment efficacy of diphenylcyclopropenone (DPCP) for alopecia areata Turkish journal of medical sciences, 2020, 12-17, Volume: 50, Issue:8 Topics: Adolescent; Adult; Alopecia Areata; Child; Child, Preschool; Cyclopropanes; Female; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult	2020
Home-based contact immunotherapy with diphenylcyclopropenone improves compliance with the recommended follow-up for patients with alopecia areata: A retrospective cohort study. Journal of the American Academy of Dermatology, 2020, Volume: 82, Issue:5 Topics: Administration, Cutaneous; Alopecia Areata; Cyclopropanes; Follow-Up Studies; Humans; Immunotherapy; Lost to Follow-Up; Patient Compliance; Retrospective Studies; Self Care	2020
Therapeutic outcome of diphencyprone and its correlation with serum cytokine profile in alopecia areata. The Journal of dermatological treatment, 2022, Volume: 33, Issue:1 Topics: Alopecia Areata; Cyclopropanes; Cytokines; Humans; Treatment Outcome	2022
Topical immunotherapy with diphenylcyclopropenone in patients with alopecia areata: A large retrospective study of 757 patients. Dermatologic therapy, 2020, Volume: 33, Issue:6 Topics: Administration, Topical; Alopecia Areata; Cyclopropanes; Humans; Immunotherapy; Retrospective Studies	2020
Limited efficacy of diphenylcyclopropenone in the treatment of alopecia areata: Experience from a Tertiary Healthcare Institution in Singapore. Dermatologic therapy, 2020, Volume: 33, Issue:6 Topics: Alopecia Areata; Cyclopropanes; Humans; Retrospective Studies; Singapore; Tertiary Healthcare; Treatment Outcome	2020
Diphenylcyclopropenone plays an effective therapeutic role by up-regulating the TSLP/OX40L/IL-13 pathway in severe alopecia areata. Experimental dermatology, 2021, Volume: 30, Issue:2 Topics: Administration, Cutaneous; Adolescent; Adult; Alopecia Areata; Child; Cyclopropanes; Cytokines; Dermatologic Agents; Female; Gene Expression; Humans; Interferon-gamma; Interleukin-13; Interleukin-4; Interleukin-5; Male; Middle Aged; OX40 Ligand; Prospective Studies; Scalp; Signal Transduction; Young Adult	2021
Home-based contact immunotherapy with diphenylcyclopropenone for alopecia areata is as effective and safe as clinic-based treatment in patients with stable disease: A retrospective study of 40 patients. Journal of the American Academy of Dermatology, 2018, Volume: 78, Issue:3 Topics: Adult; Age Factors; Alopecia Areata; Cyclopropanes; Humans; Immunotherapy; Middle Aged; Photosensitizing Agents; Retrospective Studies; Self Care; Young Adult	2018
Subclinical sensitization with diphenylcyclopropenone is sufficient for the treatment of alopecia areata: Retrospective analysis of 159 cases. Journal of the American Academy of Dermatology, 2018, Volume: 78, Issue:3 Topics: Adolescent; Adult; Aged; Alopecia Areata; Cyclopropanes; Dermatologic Agents; Female; Hair; Humans; Immunotherapy; Male; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Treatment Outcome; Young Adult	2018
Efficacy of topical diphenylcyclopropenone maintenance treatment for patients with alopecia areata: A retrospective study. Journal of the American Academy of Dermatology, 2018, Volume: 78, Issue:1 Topics: Administration, Topical; Adult; Alopecia Areata; Cyclopropanes; Female; Humans; Maintenance Chemotherapy; Male; Retrospective Studies; Treatment Outcome	2018
Diphenylcyclopropenone for alopecia areata: a U.K. survey. The British journal of dermatology, 2018, Volume: 179, Issue:2 Topics: Administration, Topical; Adult; Alopecia Areata; Cyclopropanes; Humans; Practice Patterns, Physicians'; Surveys and Questionnaires; United Kingdom	2018
STABILITY OF SOLUTIONS OF 2,3-DIPHENYLCYCLOPROPENONE IN VARIOUS SOLVENTS. A NOVEL FORMULA - DIPHENYLCYCLOPROPENONE IN ISOPROPANOL MAY BE USEFUL IN TOPICAL THERAPY OF PATIENTS WITH ALOPECIA AREATA. Acta poloniae pharmaceutica, 2017, Volume: 74, Issue:2 Topics: 2-Propanol; Acetone; Administration, Topical; Alopecia Areata; Chemistry, Pharmaceutical; Cyclopropanes; Drug Compounding; Drug Stability; Ethanol; Humans; Immunologic Factors; Light; Photolysis; Propylene Glycol; Solvents; Temperature; Time Factors	2017
STUDIES ON STABILITY OF 2,3-DIPHENYLCYCLOPROPENONE IN CONTACT WITH WATER AND AQUEOUS NaCI SOLUTIONS. CONCLUSIONS FOR PURPOSE OF TOPICAL THERAPY OF PATIENTS WITH ALOPECIA AREATA. Acta poloniae pharmaceutica, 2016, Volume: 73, Issue:6 Topics: Administration, Topical; Alopecia Areata; Cyclopropanes; Drug Stability; Drug Storage; Humans; Propylene Glycol; Sodium Chloride; Temperature; Time Factors; Water	2016
Serum level of IL-4 predicts response to topical immunotherapy with diphenylcyclopropenone in alopecia areata. Experimental dermatology, 2020, Volume: 29, Issue:3 Topics: Adolescent; Adult; Alopecia Areata; Child; Child, Preschool; Cyclopropanes; Cytokines; Dermoscopy; Female; Humans; Immunoglobulin E; Immunotherapy; Interferon-gamma; Interleukin-10; Interleukin-12 Subunit p35; Interleukin-4; Male; Middle Aged; Young Adult	2020
Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata: a retrospective case series. Archives of dermatological research, 2019, Volume: 311, Issue:8 Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Anthralin; Child; Cyclopropanes; Dermatologic Agents; Drug Therapy, Combination; Female; Hair; Humans; Immunologic Factors; Male; Middle Aged; Pruritus; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult	2019
Treatment of chronic extensive alopecia areata by diphenylcyclopropenone alone versus in combination with anthralin. Dermatologic therapy, 2019, Volume: 32, Issue:5 Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Anthralin; Child; Child, Preschool; Chronic Disease; Cyclopropanes; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Hair; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult	2019
Immunotherapy for resistant and/or severe alopecia areata in a university hospital setting in Northern Mexico. The Australasian journal of dermatology, 2020, Volume: 61, Issue:1 Topics: Adjuvants, Immunologic; Adolescent; Adult; Alopecia Areata; Child; Child, Preschool; Cyclobutanes; Cyclopropanes; Female; Hospitals, University; Humans; Immunotherapy; Male; Mexico; Middle Aged; Retrospective Studies; Young Adult	2020
Management of occupational hazards in healthcare: exposure to diphencyprone. BMJ case reports, 2013, Feb-15, Volume: 2013 Topics: Alopecia Areata; Cyclopropanes; Diagnosis, Differential; Drug Eruptions; Female; Humans; Medical Laboratory Personnel; Occupational Diseases; Occupational Exposure	2013
PTPN22 gene polymorphism in Egyptian alopecia areata patients and its impact on response to diphencyprone immunotherapy. Gene, 2013, Jul-10, Volume: 523, Issue:2 Topics: Adolescent; Adult; Alleles; Alopecia Areata; Case-Control Studies; Cyclopropanes; Egypt; Female; Gene Frequency; Genotype; Humans; Immunotherapy; Male; Polymorphism, Single Nucleotide; Protein Tyrosine Phosphatase, Non-Receptor Type 22; Recurrence; Treatment Outcome; Young Adult	2013
Topical immunomodulation with diphenylcyclopropenone for alopecia areata: the Lebanese experience. International journal of dermatology, 2013, Volume: 52, Issue:12 Topics: Adult; Alopecia Areata; Cyclopropanes; Female; Hair; Humans; Immunologic Factors; Lebanon; Male; Recurrence; Retrospective Studies; Treatment Outcome; Young Adult	2013
Clinical efficacy of diphenylcyclopropenone in alopecia areata: retrospective data analysis of 50 patients. Journal of the American Academy of Dermatology, 2014, Volume: 71, Issue:3 Topics: Adolescent; Adult; Alopecia Areata; Child; Child, Preschool; Cyclopropanes; Female; Humans; Immunologic Factors; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult	2014
Chinese experience in the treatment of alopecia areata with diphenylcyclopropenone. The Journal of dermatology, 2015, Volume: 42, Issue:2 Topics: Administration, Cutaneous; Alopecia Areata; China; Cyclopropanes; Female; Humans; Male; Prognosis; Recurrence; Severity of Illness Index; Time Factors; Treatment Outcome	2015
Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series. Journal of the American Academy of Dermatology, 2015, Volume: 72, Issue:4 Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Alopecia Areata; Anthralin; Apoptosis; CD4-CD8 Ratio; Child; Cyclopropanes; Cytokines; Drug Eruptions; Drug Evaluation; Drug Therapy, Combination; Female; Folliculitis; Follow-Up Studies; Humans; Hyperpigmentation; Immunotherapy; Male; Middle Aged; Pruritus; Retrospective Studies; Severity of Illness Index; T-Lymphocyte Subsets; Treatment Outcome; Young Adult	2015
Osteopontin: a new facilitating factor in alopecia areata pathogenesis? Acta dermatovenerologica Croatica : ADC, 2015, Volume: 23, Issue:1 Topics: Adult; Alopecia Areata; Cyclopropanes; Female; Humans; Male; Middle Aged; Osteopontin; Retrospective Studies; Young Adult	2015
Diphencyprone Treatment of Alopecia Areata: Postulated Mechanism of Action and Prospects for Therapeutic Synergy with RNA Interference. The journal of investigative dermatology. Symposium proceedings, 2015, Volume: 17, Issue:2 Topics: Alopecia Areata; Autoimmune Diseases; Combined Modality Therapy; Cyclopropanes; Dermatologic Agents; Down-Regulation; Gene Expression Regulation; Humans; Inflammation; RNA Interference; Up-Regulation	2015
Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients. The journal of investigative dermatology. Symposium proceedings, 2015, Volume: 17, Issue:2 Topics: Administration, Cutaneous; Adolescent; Adult; Alopecia; Alopecia Areata; Child; Cyclopropanes; Dermatologic Agents; Female; Hair; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Severity of Illness Index; Thyroid Diseases; Time Factors; Treatment Outcome; Young Adult	2015
Retrospective review of diphencyprone in the treatment of alopecia areata. Clinical and experimental dermatology, 2016, Volume: 41, Issue:4 Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Aged; Alopecia Areata; Cyclopropanes; Eczema; Female; Hair; Headache; Humans; Hyperpigmentation; Immunotherapy; Lymphadenopathy; Male; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome	2016
Topical immunotherapy with diphenylcyclopropenone-induced vitiligo. Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology, 2016, Volume: 18, Issue:4 Topics: Administration, Topical; Alopecia Areata; Cyclopropanes; Dermatologic Agents; Dose-Response Relationship, Drug; Humans; Immunotherapy; Male; Young Adult	2016
Possible advantage of imiquimod and diphenylcyclopropenone combined treatment versus diphenylcyclopropenone alone: An observational study of nonresponder patients with alopecia areata. The Australasian journal of dermatology, 2017, Volume: 58, Issue:3 Topics: Adjuvants, Immunologic; Adolescent; Adult; Alopecia Areata; Aminoquinolines; Child; Cyclopropanes; Drug Therapy, Combination; Female; Humans; Imiquimod; Male; Photosensitizing Agents; Retreatment; Young Adult	2017
Complex Interaction Between Diphenylcyclopropenone and Immune Responses in Alopecia Areata. Scandinavian journal of immunology, 2016, Volume: 84, Issue:5 Topics: Alopecia Areata; CD40 Antigens; CD40 Ligand; CTLA-4 Antigen; Cyclopropanes; Gene Expression; Humans; Immunity, Innate; Photosensitizing Agents; T-Lymphocytes, Regulatory	2016
Efficacy of superficial cryotherapy on the eyebrows of patients with alopecia universalis also treated with contact immunotherapy on the scalp: a prospective, split-face comparative study. International journal of dermatology, 2017, Volume: 56, Issue:2 Topics: Adolescent; Adult; Alopecia Areata; Child; Cryotherapy; Cyclopropanes; Eyebrows; Female; Hair; Humans; Immunotherapy; Male; Middle Aged; Prospective Studies; Scalp; Treatment Outcome; Young Adult	2017
Acquired hair curling after diphenylcyclopropenone immunotherapy in alopecia areata patient. Journal of the European Academy of Dermatology and Venereology : JEADV, 2017, Volume: 31, Issue:8 Topics: Alopecia Areata; Cyclopropanes; Hair; Humans; Immunotherapy; Male; Young Adult	2017
Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases. The Journal of dermatology, 2009, Volume: 36, Issue:6 Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Alopecia Areata; Child; Child, Preschool; Cyclobutanes; Cyclopropanes; Dermatologic Agents; Female; Humans; Hypersensitivity; Immunotherapy; Male; Middle Aged; Retrospective Studies; Terfenadine; Young Adult	2009
Five-year experience in the treatment of alopecia areata with DPC. Journal of the European Academy of Dermatology and Venereology : JEADV, 2010, Volume: 24, Issue:3 Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Child; Child, Preschool; Cyclopropanes; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Immunotherapy; Infant; Male; Middle Aged; Patient Satisfaction; Powders; Retrospective Studies; Time Factors; Treatment Outcome; Young Adult	2010
Pigmented contact dermatitis due to therapeutic sensitizer as complication of contact immunotherapy in alopecia areata. The Journal of dermatology, 2010, Volume: 37, Issue:10 Topics: Adolescent; Adult; Aged; Alopecia Areata; Child; Cyclopropanes; Dermatitis, Contact; Dermatologic Agents; Female; Humans; Hyperpigmentation; Immunotherapy; Male; Middle Aged; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome; Young Adult	2010
Phototherapy as a useful therapeutic option in the treatment of diphenylcyclopropenone-induced vitiligo. Acta dermato-venereologica, 2010, Volume: 90, Issue:6 Topics: Adult; Alopecia Areata; Cyclopropanes; Humans; Male; Radiation Dosage; Treatment Outcome; Ultraviolet Therapy; Vitiligo	2010
Narrow-band ultraviolet B treatment for diphenylcyclopropenone-induced vitiliginous lesions. Acta dermato-venereologica, 2012, Volume: 92, Issue:1 Topics: Adolescent; Adult; Alopecia Areata; Cyclopropanes; Drug Eruptions; Female; Humans; Male; Ultraviolet Therapy; Vitiligo; Warts	2012
The contact sensitizer diphenylcyclopropenone has adjuvant properties in mice and potential application in epicutaneous immunotherapy. Allergy, 2012, Volume: 67, Issue:5 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Alopecia Areata; Anaphylaxis; Animals; Asthma; Cyclopropanes; Desensitization, Immunologic; Disease Models, Animal; Epitopes; Female; Immunoglobulin G; Interleukin-10; Interleukin-4; Lymphocyte Activation; Mice; Mice, Inbred CBA; T-Lymphocytes	2012
The safety and efficacy of diphencyprone for the treatment of alopecia areata in children. Archives of dermatology, 2012, Volume: 148, Issue:9 Topics: Adolescent; Alopecia Areata; Child; Child, Preschool; Cyclopropanes; Humans; Infant; Retrospective Studies	2012
Efficacy and safety of diphenylcyclopropenone among Chinese patients with steroid resistant and extensive alopecia areata. Journal of the European Academy of Dermatology and Venereology : JEADV, 2013, Volume: 27, Issue:3 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Alopecia Areata; Child; China; Cyclopropanes; Female; Humans; Male; Prognosis; Young Adult	2013
Squalene-containing nanostructured lipid carriers promote percutaneous absorption and hair follicle targeting of diphencyprone for treating alopecia areata. Pharmaceutical research, 2013, Volume: 30, Issue:2 Topics: Alopecia Areata; Animals; Cyclopropanes; Delayed-Action Preparations; Drug Delivery Systems; Female; Hair Follicle; Keratinocytes; Mice; Mice, Nude; Nanostructures; Particle Size; Phosphatidylcholines; Skin; Skin Absorption; Squalene; Surface-Active Agents	2013
Langerhans cells that express matrix metalloproteinase 9 increase in human dermis during sensitization to diphenylcyclopropenone in patients with alopecia areata. The British journal of dermatology, 2002, Volume: 147, Issue:2 Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Antigens, CD1; Cyclopropanes; Dermatitis, Contact; Dermis; Desensitization, Immunologic; Female; Humans; Immunohistochemistry; Langerhans Cells; Male; Matrix Metalloproteinase 9	2002
Urticaria after topical immunotherapy with diphenylcyclopropenone. Contact dermatitis, 2002, Volume: 47, Issue:5 Topics: Administration, Cutaneous; Adolescent; Adult; Alopecia Areata; Cyclopropanes; Diagnosis, Differential; Drug Hypersensitivity; Female; Humans; Immunotherapy; Male; Urticaria	2002
Restoration of hair growth with topical diphencyprone in mouse and rat models of alopecia areata. Journal of the American Academy of Dermatology, 2003, Volume: 49, Issue:6 Topics: Administration, Topical; Alopecia Areata; Animals; Cyclopropanes; Disease Models, Animal; Female; Hair; Immunohistochemistry; Mice; Mice, Inbred C3H; Rats; Skin	2003
Bald spots on a young girl. The Journal of family practice, 2004, Volume: 53, Issue:1 Topics: Administration, Topical; Alopecia Areata; Anti-Inflammatory Agents; Aromatherapy; Child; Cyclopropanes; Diagnosis, Differential; Female; Humans; Immunotherapy; Injections, Intralesional; Remission, Spontaneous; Triamcinolone Acetonide	2004
Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study. The British journal of dermatology, 2004, Volume: 150, Issue:5 Topics: Adult; Alopecia Areata; Antigens, Differentiation, T-Lymphocyte; Antigens, Neoplasm; Apoptosis; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chemokine CCL27; Chemokines, CC; Cyclin-Dependent Kinase Inhibitor p16; Cyclopropanes; Factor VIII; Female; Hair Follicle; Humans; Immunoenzyme Techniques; Inhibitor of Apoptosis Proteins; Male; Membrane Glycoproteins; Microtubule-Associated Proteins; Middle Aged; Neoplasm Proteins; Survivin; Vascular Endothelial Growth Factors	2004
The progressive state, in contrast to the stable or regressive state of alopecia areata, is reflected in peripheral blood mononuclear cells. Experimental dermatology, 2004, Volume: 13, Issue:7 Topics: Adolescent; Adult; Aged; Alopecia Areata; B7-1 Antigen; CD40 Antigens; CD40 Ligand; Child; Cyclopropanes; Cytokines; Disease Progression; Female; Flow Cytometry; Humans; Inflammation; Leukocytes, Mononuclear; Ligands; Lymphocyte Activation; Male; Middle Aged; Receptors, IgG; Time Factors; Tumor Necrosis Factor-alpha	2004
Topical immunotherapy with diphencyprone in the treatment of extensive and/or long-lasting alopecia areata. Journal of the European Academy of Dermatology and Venereology : JEADV, 2005, Volume: 19, Issue:3 Topics: Adult; Alopecia Areata; Cyclopropanes; Female; Haptens; Humans; Immunotherapy; Male	2005
Fexofenadine, an H1-receptor antagonist, partially but rapidly inhibits the itch of contact dermatitis induced by diphenylcyclopropenone in patients with alopecia areata. The Journal of dermatology, 2006, Volume: 33, Issue:2 Topics: Adolescent; Adult; Aged; Alopecia Areata; Cohort Studies; Cyclopropanes; Dermatitis, Contact; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Histamine H1 Antagonists; Humans; Male; Middle Aged; Prospective Studies; Pruritus; Risk Assessment; Severity of Illness Index; Terfenadine; Treatment Outcome	2006
Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone. Archives of dermatological research, 2007, Volume: 299, Issue:5-6 Topics: Adolescent; Adult; Alopecia Areata; Biopsy; CD8-Positive T-Lymphocytes; Cell Movement; Cyclopropanes; Dermis; Female; Hair; Hair Follicle; Humans; Immunotherapy; Male; Middle Aged; Scalp; T-Lymphocyte Subsets	2007
Cytokine patterns in alopecia areata before and after topical immunotherapy. The Journal of investigative dermatology, 1995, Volume: 104, Issue:5 Suppl Topics: Administration, Cutaneous; Alopecia Areata; Cyclopropanes; Gene Expression; Humans; Interferons; Interleukins; Polymerase Chain Reaction; T-Lymphocytes	1995
Effects of acute, low-dose UVB radiation on the induction of contact hypersensitivity to diphenylcyclopropenone in man. Archives of dermatological research, 1993, Volume: 285, Issue:1-2 Topics: Adolescent; Adult; Aged; Alopecia Areata; Antigens, CD; Antigens, CD1; Cyclopropanes; Dermatitis, Contact; Female; Humans; Lymphocyte Activation; Macrophages; Male; Middle Aged; Skin; T-Lymphocytes; Ultraviolet Rays	1993
Diphencyprone is not detectable in serum or urine following topical application. Acta dermato-venereologica, 1994, Volume: 74, Issue:4 Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Chromatography, High Pressure Liquid; Cyclopropanes; Female; Humans; Male; Middle Aged	1994
Topical immunotherapy of alopecia areata. Dermatologic clinics, 1993, Volume: 11, Issue:3 Topics: Administration, Topical; Allergens; Alopecia Areata; Cyclobutanes; Cyclopropanes; Hair; Humans; Immunotherapy	1993
Vitiligo complicating diphencyprone sensitization therapy for alopecia universalis. The British journal of dermatology, 1995, Volume: 133, Issue:3 Topics: Adult; Alopecia Areata; Cyclopropanes; Drug Eruptions; Humans; Male; Scalp Dermatoses; Vitiligo	1995
Alopecia areata in a patient with candidiasis-endocrinopathy syndrome: unsuccessful treatment trial with diphenylcyclopropenone. Dermatology (Basel, Switzerland), 1995, Volume: 191, Issue:1 Topics: Adolescent; Adult; Alopecia Areata; Child; Child, Preschool; Cyclopropanes; Follow-Up Studies; Hair; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Infant, Newborn; Male; Polyendocrinopathies, Autoimmune; Scalp; Spleen	1995
Significance of cytokine patterns in alopecia areata before and after therapeutic allergic contact dermatitis. The Journal of investigative dermatology, 1996, Volume: 106, Issue:2 Topics: Alopecia Areata; Cyclopropanes; Cytokines; Dermatitis, Contact; Humans; RNA, Messenger	1996
Growth factor mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. Acta dermato-venereologica, 1996, Volume: 76, Issue:1 Topics: Administration, Topical; Adult; Aged; Alopecia Areata; Base Sequence; Chromatography, High Pressure Liquid; Cyclopropanes; Desensitization, Immunologic; DNA Primers; Follow-Up Studies; Gene Expression Regulation; Growth Substances; Humans; Middle Aged; Molecular Sequence Data; Polymerase Chain Reaction; RNA, Messenger; Treatment Outcome	1996
Loss of contact sensitization evaluated by laser Doppler blood flowmetry and transepidermal water loss measurement. Contact dermatitis, 1996, Volume: 34, Issue:4 Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Blood Flow Velocity; Child; Child, Preschool; Cyclopropanes; Dermatitis, Allergic Contact; Desensitization, Immunologic; Female; Humans; Immunotherapy; Laser-Doppler Flowmetry; Male; Middle Aged; Patch Tests; Skin; Skin Physiological Phenomena; Water Loss, Insensible	1996
Hazards in the use of diphencyprone. The British journal of dermatology, 1996, Volume: 134, Issue:6 Topics: Alopecia Areata; Cyclopropanes; Drug Eruptions; Health Personnel; Humans; Occupational Diseases	1996
New treatments for alopecia areata. Lancet (London, England), 1997, Jan-25, Volume: 349, Issue:9047 Topics: Alopecia Areata; Child; Cyclopropanes; Humans; Immunotherapy; PUVA Therapy	1997
IFN-gamma-induced HLA-DR but not ICAM-1 expression on cultured dermal papilla cells is downregulated by TNF-alpha. Archives of dermatological research, 1997, Volume: 289, Issue:8 Topics: Adult; Alopecia Areata; Cells, Cultured; Cyclopropanes; Down-Regulation; HLA-DR Antigens; Humans; Intercellular Adhesion Molecule-1; Interferon-gamma; Interleukin-1; Skin; Tumor Necrosis Factor-alpha	1997
Severe urticarial reaction to diphenylcyclopropenone therapy for alopecia areata. Journal of the American Academy of Dermatology, 1999, Volume: 40, Issue:1 Topics: Administration, Topical; Adult; Alopecia Areata; Cyclopropanes; Humans; Male; Urticaria	1999
Pronounced perifollicular lymphocytic infiltrates in alopecia areata are associated with poor treatment response to diphencyprone. European journal of dermatology : EJD, 1999, Volume: 9, Issue:2 Topics: Administration, Topical; Alopecia Areata; Case-Control Studies; Cyclopropanes; Hair Follicle; Humans; Immunotherapy; Lymphocytes; Scalp; Treatment Outcome	1999
Diphenylcyclopropenone: An important agent known to cause depigmentation. Dermatology (Basel, Switzerland), 1999, Volume: 199, Issue:2 Topics: Alopecia Areata; Contraindications; Cyclopropanes; Humans; Hypopigmentation	1999
[Alopecia areata and its treatment]. Duodecim; laaketieteellinen aikakauskirja, 1997, Volume: 113, Issue:17 Topics: Adolescent; Adult; Aged; Alopecia Areata; Child; Cyclopropanes; Female; Humans; Male; Middle Aged	1997
Alopecia areata-like hair loss in C3H/HeJ mice and DEBR rats can be reversed using topical diphencyprone. The journal of investigative dermatology. Symposium proceedings, 1999, Volume: 4, Issue:3 Topics: Administration, Topical; Alopecia Areata; Animals; Cyclopropanes; Mice; Rats	1999
Hazards in the use of diphencyprone. Allergy, 2000, Volume: 55, Issue:2 Topics: Alopecia Areata; Cyclopropanes; Dermatitis, Contact; Dermatitis, Occupational; Female; Humans; Middle Aged; Nurses	2000
DPCP for the treatment of alopecia areata. Skin therapy letter, 2000, Volume: 5, Issue:5 Topics: Administration, Topical; Alopecia Areata; Cyclopropanes; Hair; Humans; Immunotherapy	2000
Predictive model for immunotherapy of alopecia areata with diphencyprone. Archives of dermatology, 2001, Volume: 137, Issue:8 Topics: Adolescent; Adult; Aged; Alopecia Areata; Child; Cyclopropanes; Female; Humans; Immunotherapy; Male; Middle Aged; Models, Theoretical; Retrospective Studies	2001
Impaired responses of peripheral blood mononuclear cells to T-cell stimulants in alopecia areata patients with a poor response to topical immunotherapy. The British journal of dermatology, 2001, Volume: 145, Issue:3 Topics: Adolescent; Adult; Allergens; Alopecia Areata; Cell Culture Techniques; Cell Division; Child; Cyclopropanes; Cytokines; Enterotoxins; Female; Humans; Immune Tolerance; Immunotherapy; Male; Middle Aged; Phytohemagglutinins; Prognosis; T-Lymphocytes; Treatment Outcome	2001
Diphencyprone for the treatment of alopecia areata: more data and new aspects. Archives of dermatology, 2002, Volume: 138, Issue:1 Topics: Alopecia Areata; Clinical Trials as Topic; Cyclopropanes; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Risk Assessment; Severity of Illness Index; Treatment Outcome	2002
[Alopecia areata]. Therapeutische Umschau. Revue therapeutique, 2002, Volume: 59, Issue:5 Topics: Adrenal Cortex Hormones; Alopecia Areata; Cyclopropanes; Diagnosis, Differential; Humans; Prognosis; PUVA Therapy; Risk Factors	2002
Topical immunotherapy for alopecia areata: re-evaluation of 139 cases after an additional follow-up period of 19 months. Dermatology (Basel, Switzerland), 1992, Volume: 184, Issue:3 Topics: Administration, Topical; Alopecia Areata; Cyclobutanes; Cyclopropanes; Follow-Up Studies; Humans; Immunotherapy; Male; Prognosis	1992
Therapy of alopecia areata with diphencyprone. The British journal of dermatology, 1992, Volume: 127, Issue:6 Topics: Adolescent; Adult; Alopecia Areata; Cyclopropanes; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Remission Induction	1992
Treatment of alopecia areata with diphenylcyclopropenone. Journal of the American Academy of Dermatology, 1992, Volume: 26, Issue:2 Pt 1 Topics: Alopecia Areata; Cyclopropanes; Humans; Time Factors	1992
Alopecia areata in children: response to treatment with diphencyprone. The British journal of dermatology, 1991, Volume: 125, Issue:2 Topics: Adolescent; Allergens; Alopecia Areata; Child; Child, Preschool; Cyclopropanes; Dermatitis, Contact; Eczema; Female; Humans; Male; Scalp Dermatoses; Time Factors	1991
Successful treatment of alopecia areata using the contact allergen diphencyprone. The British journal of dermatology, 1991, Volume: 124, Issue:2 Topics: Alopecia Areata; Cyclopropanes; Female; Humans; Male	1991
Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone. Journal of the American Academy of Dermatology, 1991, Volume: 24, Issue:2 Pt 1 Topics: Adolescent; Adult; Aged; Alopecia Areata; Child; Child, Preschool; Cyclopropanes; Female; Humans; Immunotherapy; Male; Middle Aged; Nail Diseases; Prognosis; Sleep Wake Disorders	1991
Topical immunotherapy with contact allergens in alopecia areata: evidence for non-specific systemic suppression of cellular immune reactions. Archives of dermatological research, 1991, Volume: 283, Issue:2 Topics: Administration, Cutaneous; Adolescent; Adult; Allergens; Alopecia Areata; Cyclobutanes; Cyclopropanes; Female; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Immunotherapy; Male; Middle Aged	1991
Erythema multiforme-like eruptions: a rare side effect of topical immunotherapy with diphenylcyclopropenone. Dermatologica, 1990, Volume: 180, Issue:1 Topics: Administration, Topical; Adult; Alopecia Areata; Cyclobutanes; Cyclopropanes; Drug Eruptions; Erythema Multiforme; Female; Humans; Middle Aged	1990
Alopecia areata treated with diphencyprone: is an allergic response necessary? The British journal of dermatology, 1990, Volume: 122, Issue:5 Topics: Adolescent; Adult; Allergens; Alopecia Areata; Cyclopropanes; Female; Humans; Male; Middle Aged	1990
Treatment of alopecia areata with diphenylcyclopropenone. Acta dermato-venereologica, 1985, Volume: 65, Issue:3 Topics: Alopecia Areata; Cyclopropanes; Humans	1985
[Onset of the effect in treatment of alopecia areata with diphenylcyclopropenone]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1989, Volume: 40, Issue:5 Topics: Administration, Topical; Adult; Alopecia Areata; Cyclopropanes; Dermatologic Agents; Female; Hair; Humans; Long-Term Care	1989
[Treatment of alopecia areata of the eyebrow with diphenylcyclopropenone and its possible risks]. Zeitschrift fur Hautkrankheiten, 1989, Oct-15, Volume: 64, Issue:10 Topics: Administration, Topical; Alopecia Areata; Cyclopropanes; Eyebrows; Humans; Male; Middle Aged; Risk Factors	1989
Vitiligo and topical allergens. Dermatologica, 1989, Volume: 179, Issue:3 Topics: Administration, Topical; Allergens; Alopecia Areata; Cyclopropanes; Humans; Vitiligo	1989
Induction of hair growth in alopecia totalis with diphencyprone sensitization. Clinical and experimental dermatology, 1989, Volume: 14, Issue:2 Topics: Adult; Alopecia; Alopecia Areata; Child; Cyclopropanes; Female; Hair; Humans; Male	1989
Contact urticaria during topical immunotherapy. Contact dermatitis, 1989, Volume: 21, Issue:3 Topics: Administration, Topical; Adult; Alopecia Areata; Cyclobutanes; Cyclopropanes; Dermatitis, Contact; Dinitrochlorobenzene; Female; Humans; Immunotherapy; Male; Urticaria	1989
Topical immunotherapy changes the composition of the peribulbar infiltrate in alopecia areata. Archives of dermatological research, 1986, Volume: 278, Issue:3 Topics: Administration, Topical; Alopecia Areata; Autoimmune Diseases; Cyclopropanes; Hair; Humans; T-Lymphocytes	1986
Treatment of alopecia areata with diphencyprone. The Australasian journal of dermatology, 1988, Volume: 29, Issue:1 Topics: Administration, Topical; Adolescent; Adult; Aged; Alopecia Areata; Child; Cyclopropanes; Drug Eruptions; Female; Humans; Male; Middle Aged	1988
Thymopentin in the treatment of severe alopecia areata. Dermatologica, 1988, Volume: 177, Issue:3 Topics: Adjuvants, Immunologic; Adolescent; Adult; Alopecia Areata; Cyclobutanes; Cyclopropanes; Female; Humans; Male; Middle Aged; Peptide Fragments; Thymopentin; Thymopoietins; Thymus Hormones	1988
[Therapy of alopecia areata with diphenylcyclopropenone]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1985, Volume: 36, Issue:6 Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Chemical Phenomena; Chemistry; Cyclopropanes; Dermatitis, Contact; Drug Eruptions; Female; Humans; Male; Middle Aged	1985
Vitiligo as a reaction to topical treatment with diphencyprone. Dermatologica, 1988, Volume: 177, Issue:3 Topics: Administration, Topical; Adolescent; Adult; Aged; Alopecia Areata; Child; Cyclopropanes; Female; Humans; Male; Middle Aged; Vitiligo	1988
[Sensitization therapy in severe alopecia areata]. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 1988, Volume: 123, Issue:11 Topics: Adolescent; Adult; Aged; Allergens; Alopecia Areata; Child; Child, Preschool; Cyclobutanes; Cyclopropanes; Female; Humans; Immunization; Male; Middle Aged	1988
[Therapy of alopecia areata with diphenylcyclopropenone]. Zeitschrift fur Hautkrankheiten, 1988, Feb-15, Volume: 63, Issue:2 Topics: Administration, Topical; Adolescent; Adult; Aged; Alopecia Areata; Cyclopropanes; Drug Administration Schedule; Female; Humans; Male; Middle Aged	1988
Patterns of hair regrowth in alopecia areata. Dermatologica, 1988, Volume: 176, Issue:5 Topics: Adjuvants, Immunologic; Adolescent; Adult; Alopecia Areata; Child; Cyclobutanes; Cyclopropanes; Female; Hair; Humans; Male; Minoxidil	1988
Treatment of alopecia areata with diphencyprone. Dermatologica, 1985, Volume: 171, Issue:3 Topics: Adolescent; Adult; Alopecia Areata; Child; Chronic Disease; Cyclopropanes; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Male; Middle Aged	1985